Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258999 · ClinicalTrials.gov registry record · NA
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT00258999 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 600 participants.
The verdict
NCT00258999, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
The study will evaluate the clinical utilization of skin Cholesterol (SC) for cardiovascular risk assessment in asymptomatic individuals at low, intermediate and high risk based on Framingham global risk estimates. Preliminary studies have suggested that SC is an easy to measure, noninvasive marker of cardiovascular risk. This study is intended to provide further data in support of broader clearance by the Food and Drug Administration for the use of SC as a tool to identify asymptomatic patients at increased risk of cardiovascular disease. Currently, SC testing is cleared for use as part of risk assessment in subject suspected of having significant multi-vessel disease. The current study data will be used to support the use of SC testing as part of cardiovascular risk assessment in subjects without suspected coronary artery disease (CAD).
Interventions
- DEVICE Skin Cholesterol Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00258999
The ClinicalTrials.gov registry entry for NCT00258999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Skin Cholesterol Testing is the first listed.
NCT00258999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00258999 about?
NCT00258999 is a clinical study titled "Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study". The study will evaluate the clinical utilization of skin Cholesterol (SC) for cardiovascular risk assessment in asymptomatic individuals at low, intermediate and high risk based on Framingham global risk estimates. Preliminary studies have suggested that SC is an easy to measure, noninvasive marker...
What is the current status of trial NCT00258999?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2005-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00258999?
The interventions under investigation include: Skin Cholesterol Testing (DEVICE).
Who is sponsoring clinical trial NCT00258999?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.